Universe Pharmaceuticals (UPC) Receivables - Net (2020 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Receivables - Net for 6 consecutive years, with $13.0 billion as the latest value for Q3 2025.
- Quarterly Receivables - Net rose 265.14% to $13.0 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.0 billion through Sep 2025, up 265.14% year-over-year, with the annual reading at $13.0 billion for FY2025, 265.14% up from the prior year.
- Receivables - Net hit $13.0 billion in Q3 2025 for Universe Pharmaceuticals, up from $3.6 billion in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $13.0 billion in Q3 2025 to a low of $11.0 million in Q3 2023.
- Historically, Receivables - Net has averaged $3.3 billion across 5 years, with a median of $16.0 million in 2021.
- Biggest five-year swings in Receivables - Net: dropped 27.46% in 2023 and later surged 32242.28% in 2024.
- Year by year, Receivables - Net stood at $16.0 million in 2021, then decreased by 5.22% to $15.2 million in 2022, then decreased by 27.46% to $11.0 million in 2023, then soared by 32242.28% to $3.6 billion in 2024, then soared by 265.14% to $13.0 billion in 2025.
- Business Quant data shows Receivables - Net for UPC at $13.0 billion in Q3 2025, $3.6 billion in Q3 2024, and $11.0 million in Q3 2023.